205 related articles for article (PubMed ID: 33953745)
1. Plasma-Derived Exosomal microRNA-130a Serves as a Noninvasive Biomarker for Diagnosis and Prognosis of Oral Squamous Cell Carcinoma.
He T; Guo X; Li X; Liao C; Wang X; He K
J Oncol; 2021; 2021():5547911. PubMed ID: 33953745
[TBL] [Abstract][Full Text] [Related]
2. Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening.
He L; Ping F; Fan Z; Zhang C; Deng M; Cheng B; Xia J
Biomed Pharmacother; 2020 Jan; 121():109553. PubMed ID: 31704611
[TBL] [Abstract][Full Text] [Related]
3. Exosome-derived microRNAs in oral squamous cell carcinomas impact disease prognosis.
Chen CM; Chu TH; Chou CC; Chien CY; Wang JS; Huang CC
Oral Oncol; 2021 Sep; 120():105402. PubMed ID: 34174519
[TBL] [Abstract][Full Text] [Related]
4. Circulating Exosomal miR-27a and miR-130a Act as Novel Diagnostic and Prognostic Biomarkers of Colorectal Cancer.
Liu X; Pan B; Sun L; Chen X; Zeng K; Hu X; Xu T; Xu M; Wang S
Cancer Epidemiol Biomarkers Prev; 2018 Jul; 27(7):746-754. PubMed ID: 29739748
[No Abstract] [Full Text] [Related]
5. Down-regulation of miR-200c associates with poor prognosis of oral squamous cell carcinoma.
Song J; Zhang N; Cao L; Xiao D; Ye X; Luo E; Zhang Z
Int J Clin Oncol; 2020 Jun; 25(6):1072-1078. PubMed ID: 32162011
[TBL] [Abstract][Full Text] [Related]
6. Exosomal miR-130a-3p promotes the progression of differentiated thyroid cancer by targeting insulin-like growth factor 1.
Yin G; Kong W; Zheng S; Shan Y; Zhang J; Ying R; Wu H
Oncol Lett; 2021 Apr; 21(4):283. PubMed ID: 33732359
[TBL] [Abstract][Full Text] [Related]
7. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence.
Sueta A; Yamamoto Y; Tomiguchi M; Takeshita T; Yamamoto-Ibusuki M; Iwase H
Oncotarget; 2017 Sep; 8(41):69934-69944. PubMed ID: 29050253
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic value of serum miR-99a expression in oral squamous cell carcinoma.
Chen L; Hu J; Pan L; Yin X; Wang Q; Chen H
Cancer Biomark; 2018; 23(3):333-339. PubMed ID: 30223386
[TBL] [Abstract][Full Text] [Related]
10. Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma.
Wei H; Yu K; Liu Y; Li L; Wang G
BMC Cancer; 2020 Aug; 20(1):756. PubMed ID: 32787801
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
[TBL] [Abstract][Full Text] [Related]
13. Exosomal microRNA in plasma as a non-invasive biomarker for the recurrence of non-small cell lung cancer.
Dejima H; Iinuma H; Kanaoka R; Matsutani N; Kawamura M
Oncol Lett; 2017 Mar; 13(3):1256-1263. PubMed ID: 28454243
[TBL] [Abstract][Full Text] [Related]
14. Plasma Exosomal miR-422a and miR-125b-2-3p Serve as Biomarkers for Ischemic Stroke.
Li DB; Liu JL; Wang W; Li RY; Yu DJ; Lan XY; Li JP
Curr Neurovasc Res; 2017; 14(4):330-337. PubMed ID: 28982331
[TBL] [Abstract][Full Text] [Related]
15. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer.
Li D; Wang J; Ma LJ; Yang HB; Jing JF; Jia MM; Zhang XJ; Guo F; Gao JN
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7303-7309. PubMed ID: 32706068
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics analysis of dysregulated exosomal microRNAs derived from oral squamous cell carcinoma cells.
Masaoka T; Shinozuka K; Ohara K; Tsuda H; Imai K; Tonogi M
J Oral Sci; 2021 Mar; 63(2):174-178. PubMed ID: 33731508
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of Plasma Exosomal MicroRNA-451a as a Noninvasive Biomarker for Early Prediction of Recurrence and Prognosis of Non-Small Cell Lung Cancer.
Kanaoka R; Iinuma H; Dejima H; Sakai T; Uehara H; Matsutani N; Kawamura M
Oncology; 2018; 94(5):311-323. PubMed ID: 29533963
[TBL] [Abstract][Full Text] [Related]
18. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
[TBL] [Abstract][Full Text] [Related]
19. Serum exosomal miR-182 upregulation predicts unfavorable prognosis of esophageal squamous cell carcinoma.
Qiu ML; Li X; Lin JB; Luo RG; Liu B; Feng Z
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5412-5418. PubMed ID: 32495876
[TBL] [Abstract][Full Text] [Related]
20. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y
Oncology; 2017; 92(6):360-370. PubMed ID: 28376502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]